Skip to content

Cellular Logistics

2 viewers · 30d

Total raised

$100K

+$50K this year

2 filings since 2025 · latest Debt filed

Cumulative raised
LAST ROUND
Debt · $50K
ROUNDS
2
INVESTORS
2
FOUNDED
N/A
HQ
Madison, WI
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Cellular Logistics, Inc. is a biotechnology company operating out of Madison, Wisconsin, focused on pioneering advanced regenerative therapies for patients with various cardiovascular diseases. They aim to repair damaged heart tissue and prevent heart failure, particularly in post-heart attack patients, addressing a critical need in cardiac care.

What sets it apart

Advanced acellular biomaterial for heart regeneration

Funding history

2 rounds
Debt+1Jun 25, 2026 · $25K min
Form D
+$50K$100K total
Debt+1Mar 28, 2025 · $25K min
Form D
+$50K$50K total

Products

1 tracked

CFX™

Biomaterial Therapy

CFX™ is a cutting-edge acellular biomaterial engineered to support heart healing and curb heart failure progression. This technology activates the body's inherent repair mechanisms within damaged heart tissue, induces the development of new blood vessels, and mitigates detrimental inflammatory responses that often result in scarring. Its versatility allows to be used alone or in conjunction with other regenerative medicine approaches, boosting their effectiveness and retention in the heart.

  • Activates natural repair mechanisms
  • Stimulates new blood vessel formation
  • Reduces inflammatory responses